Last update 21 Nov 2024
Tetravalent influenza vaccine (Jiangsu Simcere)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Tetravalent influenza vaccine (Jiangsu Simcere)评价不同剂量四价流感病毒裂解疫苗在6-35月龄人群中接种的安全性和免疫原性的随机、双盲、同类疫苗对照的Ⅰ期临床试验
[Translation] A randomized, double-blind, similar vaccine-controlled phase I clinical trial to evaluate the safety and immunogenicity of different doses of quadrivalent influenza virus split vaccine in people aged 6-35 months
随机、双盲、阳性对照评价四价流感病毒裂解疫苗在3岁及以上人群中接种的免疫原性和安全性的Ⅲ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase III clinical trial to evaluate the immunogenicity and safety of quadrivalent influenza virus split vaccine in people aged 3 years and above
评价四价流感病毒裂解疫苗在3岁及以上健康人群中接种安全性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety of quadrivalent influenza virus split vaccine in healthy people aged 3 years and above
100 Clinical Results associated with Tetravalent influenza vaccine (Jiangsu Simcere)
Login to view more data
100 Translational Medicine associated with Tetravalent influenza vaccine (Jiangsu Simcere)
Login to view more data
100 Patents (Medical) associated with Tetravalent influenza vaccine (Jiangsu Simcere)
Login to view more data
100 Deals associated with Tetravalent influenza vaccine (Jiangsu Simcere)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| influenza A subtype H3N2 infection | Phase 3 | CN | 03 Mar 2023 | |
| Influenza, Human | Phase 1 | - | 15 Dec 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free